{"nct_id":"NCT04807972","title":"Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2021-05-28","start_date_type":"ACTUAL","primary_completion_date":"2024-03-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-03-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["ABBV"]}